Cell Therapy Landscape Review
Our cell therapy landscape review series offers an in-depth data-driven analysis of the cell therapy drug, trial and commercial landscape.
Put yourself at the forefront of innovation with unparalleled insights into the dynamic and fast-paced world of cell therapy development with Beacon Cell Therapy.
This Report Offers Insight Into:
- The Drug Landscape: From CAR-T cell therapy dominance, to emerging in vivo therapies
- The Trial Landscape: 2024 saw a 31% in cell therapy clinical trial initiation
- Commercial Insights: Highlighting key partnerships and investment trends
- Future Trends: Featuring expansion into autoimmune diseases and novel manufacturing innovations, such as armouring technology
Report Contents
The Drug Landscape
An analysis of all 7000+ assets in the cell therapy database by drug phase, target, disease indication, and more
The Trial Landscape
An analysis of the 5000+ clinical trials tracked on Beacon Cell Therapy and a deeper look into trends within the space
The Commercial Market
A review of cell therapy deals and mergers & acquisitions from 2024, as well as cell therapy company type and location
The Future of Cell Therapy
A glimpse into the future trajectory of the cell therapy space, with a look at armouring technologies and upcoming milestones.
Previous Cell Therapy Landscape Reviews
Cell Therapy 2024 H1 Landscape Review
An analysis of the Cell Therapy landscape in H1 of 2024
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
